Özen, B. Et Al. 2024. Favipiravir does not appear to be a major teratogen: Case series from Türkiye.. Journal of gynecology obstetrics and human reproduction , vol.53, no.1 , 102693.

Özen, B., Us, Z., Toplu, A., Vizdiklar, C., Selalmaz, Y., Çulpan, Y., ... Aşik, Z. T.(2024). Favipiravir does not appear to be a major teratogen: Case series from Türkiye.. Journal of gynecology obstetrics and human reproduction , vol.53, no.1, 102693.

Özen, Berna Et Al. "Favipiravir does not appear to be a major teratogen: Case series from Türkiye.," Journal of gynecology obstetrics and human reproduction , vol.53, no.1, 102693, 2024

Özen, Berna Et Al. "Favipiravir does not appear to be a major teratogen: Case series from Türkiye.." Journal of gynecology obstetrics and human reproduction , vol.53, no.1, pp.102693, 2024

Özen, B. Et Al. (2024) . "Favipiravir does not appear to be a major teratogen: Case series from Türkiye.." Journal of gynecology obstetrics and human reproduction , vol.53, no.1, p.102693.

@article{article, author={Berna Özen Et Al. }, title={Favipiravir does not appear to be a major teratogen: Case series from Türkiye.}, journal={Journal of gynecology obstetrics and human reproduction}, year=2024, pages={102693} }